Centessa Pharmaceuticals (CNTA) Insider Trading & Ownership $12.68 +0.08 (+0.63%) Closing price 06/18/2025 04:00 PM EasternExtended Trading$13.29 +0.61 (+4.81%) As of 06/18/2025 07:55 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Centessa Pharmaceuticals (NASDAQ:CNTA) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage7.09%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$5.87MNumber OfInsiders Selling(Last 12 Months)6Amount OfInsider Selling(Last 12 Months)$16.54M Get CNTA Insider Trade Alerts Want to know when executives and insiders are buying or selling Centessa Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address CNTA Insider Buying and Selling by Quarter Centessa Pharmaceuticals Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails5/27/2025Gregory M WeinhoffInsiderSell10,000$12.82$128,200.00 5/20/2025Saurabh SahaCEOSell55,000$12.71$699,050.00 5/16/2025Arjun GoyalDirectorBuy417,646$12.73$5,316,633.58 5/15/2025Arjun GoyalDirectorBuy44,939$12.24$550,053.36 5/1/2025Iqbal J HussainGeneral CounselSell311$14.00$4,354.00 4/28/2025Iqbal J HussainGeneral CounselSell2,080$14.01$29,140.80 4/25/2025Gregory M WeinhoffInsiderSell11,742$13.61$159,808.62 4/25/2025Iqbal J HussainGeneral CounselSell3,609$14.00$50,526.00 4/21/2025Saurabh SahaCEOSell14,656$12.29$180,122.24 3/25/2025Gregory M WeinhoffInsiderSell10,000$16.34$163,400.00 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 3/20/2025Saurabh SahaCEOSell55,000$16.69$917,950.00 3/17/2025David M ChaoInsiderSell7,000$17.17$120,190.00 3/17/2025Iqbal J HussainGeneral CounselSell6,000$16.45$98,700.00 2/20/2025Saurabh SahaCEOSell55,000$15.93$876,150.00 2/18/2025Iqbal J HussainGeneral CounselSell6,000$16.18$97,080.00 2/10/2025Karen M AndersonInsiderSell429$18.99$8,146.71 2/7/2025Karen M AndersonInsiderSell30,526$19.03$580,909.78 2/3/2025Karen M AndersonInsiderSell6,471$16.86$109,101.06 2/3/2025Tia L BushCTOSell11,000$16.86$185,460.00 1/27/2025Gregory M WeinhoffInsiderSell11,742$16.47$193,390.74 1/21/2025Saurabh SahaCEOSell55,000$15.77$867,350.00 1/15/2025Iqbal J HussainGeneral CounselSell6,000$15.29$91,740.00 12/26/2024Gregory M WeinhoffInsiderSell10,000$17.04$170,400.00 12/20/2024Saurabh SahaCEOSell55,000$17.44$959,200.00 12/17/2024Karen M AndersonInsiderSell10,624$17.32$184,007.68 12/17/2024Tia L BushCTOSell17,813$18.00$320,634.00 12/16/2024Iqbal J HussainGeneral CounselSell77,705$16.39$1,273,584.95 12/13/2024Karen M AndersonInsiderSell5,876$17.01$99,950.76 12/6/2024Saurabh SahaCEOSell87,496$18.46$1,615,176.16 11/25/2024Gregory M WeinhoffInsiderSell10,000$17.66$176,600.00 11/25/2024Saurabh SahaCEOSell299$18.23$5,450.77 11/22/2024Saurabh SahaCEOSell1,671$18.24$30,479.04 11/20/2024Saurabh SahaCEOSell55,000$16.89$928,950.00 10/25/2024Gregory M WeinhoffInsiderSell11,742$15.38$180,591.96 10/23/2024Saurabh SahaCEOSell2,592$15.32$39,709.44 10/21/2024Saurabh SahaCEOSell22,205$15.80$350,839.00 9/25/2024Gregory M WeinhoffInsiderSell16,619$15.69$260,752.11 9/20/2024Saurabh SahaCEOSell55,000$16.53$909,150.00 9/10/2024Saurabh SahaCEOSell175,000$16.52$2,891,000.00 9/9/2024Gregory M WeinhoffInsiderSell25,000$15.00$375,000.00 Trump wipes out trillions overnight… (Ad)Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out nearly $5 trillion in wealth from the S&P 500 and $6.4 trillion from the Dow Jones… Not to mention the countless trillions of dollars lost in every market around the world… leaving the major political powers scrambling in fear of Trump’s next move.Whether you take some of that wealth for yourself depends on if you watch this controversial exposé 8/22/2024Gregory M WeinhoffInsiderSell12,198$12.17$148,449.66 8/22/2024Saurabh SahaCEOSell506$12.23$6,188.38 8/20/2024Saurabh SahaCEOSell4,169$12.32$51,362.08 (Data available from 1/1/2013 forward) CNTA Insider Trading Activity - Frequently Asked Questions Who is on Centessa Pharmaceuticals' Insider Roster? The list of insiders at Centessa Pharmaceuticals includes Antoine Yver, Arjun Goyal, David M Chao, Gregory M Weinhoff, Harris Rotman, Iqbal J Hussain, Karen M Anderson, Saurabh Saha, Thomas Templeman, and Tia L Bush. Learn more on insiders at CNTA. What percentage of Centessa Pharmaceuticals stock is owned by insiders? 7.09% of Centessa Pharmaceuticals stock is owned by insiders. Learn more on CNTA's insider holdings. Which Centessa Pharmaceuticals insiders have been buying company stock? The following insider purchased CNTA shares in the last 24 months: Arjun Goyal ($5,866,686.94). How much insider buying is happening at Centessa Pharmaceuticals? Insiders have purchased a total of 462,585 CNTA shares in the last 24 months for a total of $5,866,686.94 bought. Which Centessa Pharmaceuticals insiders have been selling company stock? The following insiders have sold CNTA shares in the last 24 months: David M Chao ($120,190.00), Gregory M Weinhoff ($1,956,593.09), Harris Rotman ($270,337.06), Iqbal J Hussain ($1,645,125.75), Karen M Anderson ($1,589,896.79), Saurabh Saha ($11,328,127.11), and Tia L Bush ($506,094.00). How much insider selling is happening at Centessa Pharmaceuticals? Insiders have sold a total of 1,106,992 Centessa Pharmaceuticals shares in the last 24 months for a total of $17,416,363.80 sold. Centessa Pharmaceuticals Key ExecutivesDr. Saurabh Saha M.D. (Age 48)Ph.D., CEO & Director Compensation: $1.04MDr. David M. Chao Ph.D. (Age 56)Chief Administrative Officer Compensation: $710.3kMr. John J. Crowley CPA (Age 50)CFO and Principal Financial & Accounting Officer Ms. Tia L. Bush (Age 53)Chief Technology & Quality Officer 1 recent tradesMs. Kristen K. Sheppard Esq.J.D., Senior Vice President of Investor Relations & Corporate CommunicationsMr. Iqbal J. Hussain L.L.B. (Age 43)General Counsel, Chief Compliance Officer & Corporate Secretary 6 recent tradesMs. Karen M. Anderson (Age 56)Chief People Officer 3 recent tradesDr. Gregory M. Weinhoff M.B.A. (Age 53)M.D., Chief Business Officer Compensation: $655kDr. Mario Alberto Accardi Ph.D.President of the Orexin ProgramMs. April DovholukSenior Vice President of Development Operations More Insider Trading Tools from MarketBeat Related Companies TG Therapeutics Insider Transactions Grifols Insider Transactions Lantheus Insider Transactions Nuvalent Insider Transactions Axsome Therapeutics Insider Transactions ADMA Biologics Insider Transactions Vaxcyte Insider Transactions Akero Therapeutics Insider Transactions Rhythm Pharmaceuticals Insider Transactions Zai Lab Insider Transactions Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles 3 Summer Stocks With Insider Buying and Analyst Support3 Tightly-Held Growth Stocks Set Up for Short SqueezesTankers, Takedowns & Air Taxis: Insiders Are Buying These 3 Names3 Tech Stocks Insiders Are Buying: Speculative Plays for JuneDividend Investors Looking for an Edge? 3 Stocks Insiders Bought This page (NASDAQ:CNTA) was last updated on 6/19/2025 by MarketBeat.com Staff From Our PartnersYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | SponsoredWhy July 22nd Could Mean Big Changes for Social SecurityIn a stunning move, President Trump has authorized an AI-led transformation of federal agencies, including Soc...Altimetry | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Centessa Pharmaceuticals PLC Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share Centessa Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
